bpc-157 fibromyalgia BPC-157: What It Is, What We Know, and Why Its Use for Arthritis Remains Unproven bpc-157 fibromyalgia clinical trial –

Subcutaneous vs Intramuscular Injection There are two injection routes used in practice: Subcutaneous (SubQ) the standard approach Reconstitute BPC-157 in bacteriostatic water as directed by your provider Inject under the skin in the abdomen, away from scar tissue Rotate injection sites to prevent localised irritation BPC-157 is water-stable and does not require acetate buffers practical for daily use Intramuscular (IM) for localised muscle injury Used when targeting a specific muscle group directly Less common in research protocols

Pissios, 2017)

(2020, February 17)

It is a version of the natural peptide but is cleaved from the 176 to 191 amino acids